Gilead Sciences
GILD
#125
Rank
C$213.88 B
Marketcap
C$172.38
Share price
1.90%
Change (1 day)
33.86%
Change (1 year)

Market capitalization of Gilead Sciences (GILD)

Market cap: C$213.88 Billion

As of January 2026 Gilead Sciences has a market cap of C$213.88 Billion. This makes Gilead Sciences the world's 125th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Gilead Sciences from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026C$213.88 B0.94%
2025C$211.89 B25.9%
2024C$168.30 B25.71%
2023C$133.88 B-8.37%
2022C$146.11 B25.91%
2021C$116.04 B24.62%
2020C$93.11 B-13.33%
2019C$107.44 B-1.64%
2018C$109.23 B-7.16%
2017C$117.65 B-7.2%
2016C$126.78 B-36.48%
2015C$199.60 B21.73%
2014C$163.97 B33.67%
2013C$122.66 B121.11%
2012C$55.47 B77.4%
2011C$31.27 B7.64%
2010C$29.05 B-29.08%
2009C$40.96 B-27.65%
2008C$56.61 B32.79%
2007C$42.63 B22.3%
2006C$34.85 B23.89%
2005C$28.13 B49.17%
2004C$18.86 B17%
2003C$16.12 B51.94%
2002C$10.61 B5%
2001C$10.10 B72.49%
2000C$5.85 B70.19%
1999C$3.44 B77.54%
1998C$1.93 B18.07%
1997C$1.64 B66.75%
1996C$0.98 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Gilead Sciences was reported to be:

C$213.86 Billion
by Nasdaq info icon info icon
C$213.88 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
C$246.11 B 15.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$160.13 B-25.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$544.85 B 154.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$30.74 B-85.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$34.50 B-83.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$202.06 B-5.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$731.56 B 242.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$1.336 T 524.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$385.24 B 80.11%๐Ÿ‡บ๐Ÿ‡ธ USA